TVTX Stock Summary and Trading Ideas (Travere Therapeutics | NASDAQ:TVTX)

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Travere Therapeutics trades on the NASDAQ stock market under the symbol TVTX.

As of March 31, 2026, TVTX stock price climbed to $29.71 with 1,726,358 million shares trading.

TVTX has a beta of 1.56, meaning it tends to be more sensitive to market movements. TVTX has a correlation of 0.15 to the broad based SPY ETF.

TVTX has a market cap of $2.74 billion. This is considered a Mid Cap stock.

Last quarter Travere Therapeutics reported $130 million in Revenue and $.37 earnings per share. This fell short of revenue expectation by $-16 million and exceeded earnings estimates by $.13.

In the last 3 years, TVTX traded as high as $42.13 and as low as $5.12.

The top ETF exchange traded funds that TVTX belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.

TVTX has outperformed the market in the last year with a price return of +51.0% while the SPY ETF gained +18.4%. However, in the short term, TVTX had mixed performance relative to the market. It has underperformed in the last 3 months, returning -21.2% vs -5.1% return in SPY. But in the last 2 weeks, TVTX shares have fared better than the market returning +6.0% compared to SPY -2.5%.

TVTX support price is $26.86 and resistance is $28.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TVTX shares will trade within this expected range on the day.